Edit Drescher
Impact in
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
- Rheumatology 24
- Rheumatoid Arthritis Research and Therapies 17
- Spondyloarthritis Studies and Treatments 7
-
- Biosimilars and Bioanalytical Methods 2
- Co-authors
- Désirée M F M van der Heijde (6 shared papers)Douglas E. Schlichting (7 shared papers)Terence P. Rooney (5 shared papers)Scott D. Beattie (5 shared papers)Paul E. Emery (7 shared papers)Maria Greenwald (6 shared papers)Sujatha S. Menon (1 shared paper)Keith S. Kanik (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (7 papers)Arthritis & Rheumatology (4 papers)Lara D. Veeken (3 papers)RMD Open (2 papers)Rheumatology and Therapy (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Edit Drescher
27 papers receiving 1.7k citations
Edit Drescher's Hit Papers
Peers
Comparison fields: 5 of 61
- Rheumatology 1.2k
- Transplantation 34
- Immunology 167
- Oncology 163
- Internal Medicine 12
Countries citing papers authored by Edit Drescher
This map shows the geographic impact of Edit Drescher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Drescher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Drescher more than expected).
Fields of papers citing papers by Edit Drescher
This network shows the impact of papers produced by Edit Drescher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Drescher. The network helps show where Edit Drescher may publish in the future.
Co-authors
The 25 scholars most cited alongside Edit Drescher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study Hit paper breakdown → | 2016 | 325 |
| 2 | Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study Hit paper breakdown → | 2017 | 302 |
| 3 | Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial Hit paper breakdown → | 2018 | 290 |
| 4 | 2014 | 251 | |
| 5 | 2016 | 133 | |
| 6 | A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis Hit paper breakdown → | 2023 | 99 |
| 7 | 2015 | 93 | |
| 8 | 2012 | 87 | |
| 9 | 2022 | 21 | |
| 10 | 2019 | 18 | |
| 11 | 2018 | 17 | |
| 12 | 2020 | 16 | |
| 13 | 2021 | 15 | |
| 14 | 24-Week Results of a Blinded Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Januse Kinase 2 Inhibitor, in Combination with Traditional Disease Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis. | 2012 | 12 |
| 15 | 2022 | 11 | |
| 16 | 2022 | 10 | |
| 17 | 2025 | 7 | |
| 18 | 2025 | 6 | |
| 19 | 2025 | 5 | |
| 20 | Baricitinib, an Oral Janus Kinase (JAK) 1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to cDMARD Therapy: Results of the Phase 3 RA-BUILD Study | 2016 | 4 |
About Edit Drescher
Edit Drescher is a scholar working on Rheumatology, Immunology, Pulmonary and Respiratory Medicine, Epidemiology and Nuclear Energy and Engineering, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Spondyloarthritis Studies and Treatments (7 papers), Vasculitis and related conditions (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Rheumatology (1.2k citations), Transplantation (34 citations), Immunology (167 citations), Oncology (163 citations) and Internal Medicine (12 citations). Edit Drescher has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Désirée M F M van der Heijde, Douglas E. Schlichting, Terence P. Rooney, Scott D. Beattie, Paul E. Emery, Maria Greenwald, Sujatha S. Menon, Keith S. Kanik, Dona L. Fleishaker and Thijs K. Hendrikx. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Lara D. Veeken, RMD Open and Rheumatology and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.